Great news as expected, and way overtime.I honestly see this falling back down over the coming weeks again in usual OCC style. Just because it's approved doesn't mean squat, take a look at celgro dental."Application for inclusion on the Prostheses List is planned for submission in Q2 CY2022."If this announcement comes out soon I'd change my mind. What's the time frame on inclusion from submission? Is it short enough to keep the stock bouyed?"The Australian market entry strategy involves expanding the Key Opinion Leader network using Remplir™ in peripheral nerve repair procedures and potentially engaging a high quality distributor."The above quote worries me too. OCC's track record on actually moving product through KOL's is lack luster. And only potentially going to engage a high quality distributor? Potentially? Please....
I do hope I am wrong!
Ann: Regulatory Approval for Remplir Nerve Repair Device, page-24
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.0¢ | $45.42K | 114.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 105248 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 193037 | 5 |
View Market Depth
| Last trade - 11.49am 12/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |